CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C12304 | BRD-K31290665 | BRD-K31290665 | -- | -- | -- | Details |
| C12305 | BRD-K31290842 | BRD-K31290842 | -- | -- | -- | Details |
| C12306 | BRD-K31290914 | BRD-K31290914 | -- | -- | -- | Details |
| C12307 | BRD-K31295191 | BRD-K31295191 | -- | -- | -- | Details |
| C12308 | BRD-K31297909 | BRD-K31297909 | -- | -- | -- | Details |
| C12309 | BRD-K31300534 | BRD-K31300534 | -- | -- | -- | Details |
| C12310 | BRD-K31302860 | BRD-K31302860 | -- | -- | -- | Details |
| C12311 | BRD-K31309378 | lucitanib | FGFR1; FGFR2; FLT1; FLT4; KDR | FGFR inhibitor; VEGFR inhibitor | -- | Details |
| C12312 | BRD-K31310964 | BRD-K31310964 | -- | -- | -- | Details |
| C12313 | BRD-K31313613 | BS-181 | CDK7 | CDK inhibitor | -- | Details |
| C12314 | BRD-K31314139 | BRD-K31314139 | -- | -- | -- | Details |
| C12315 | BRD-K31315646 | BRD-K31315646 | -- | -- | -- | Details |
| C12316 | BRD-K31325635 | BRD-K31325635 | -- | -- | -- | Details |
| C12317 | BRD-K31327364 | BRD-K31327364 | -- | -- | -- | Details |
| C12318 | BRD-K31329249 | BRD-K31329249 | -- | -- | -- | Details |
| C12319 | BRD-K31329721 | centazolone | -- | -- | -- | Details |
| C12320 | BRD-K31330911 | BRD-K31330911 | -- | -- | -- | Details |
| C12321 | BRD-K31333309 | dantrolene | RYR1 | Calcium channel blocker | -- | Details |
| C12322 | BRD-K31336762 | BRD-K31336762 | -- | -- | -- | Details |
| C12323 | BRD-K31337291 | BRD-K31337291 | -- | -- | -- | Details |
| C12324 | BRD-K31339321 | lirimilast | -- | -- | -- | Details |
| C12325 | BRD-K31342827 | BRD-K31342827 | -- | -- | bisindolylmaleimide | Details |
| C12326 | BRD-K31344914 | BRD-K31344914 | -- | -- | -- | Details |
| C12327 | BRD-K31348453 | BRD-K31348453 | -- | -- | -- | Details |
| C12328 | BRD-K31354456 | BRD-K31354456 | -- | -- | -- | Details |
| C12329 | BRD-K31362741 | BRD-K31362741 | -- | -- | -- | Details |
| C12330 | BRD-K31363949 | BRD-K31363949 | -- | -- | -- | Details |
| C12331 | BRD-K31367750 | BRD-K31367750 | -- | -- | -- | Details |
| C12332 | BRD-K31369513 | BRD-K31369513 | -- | -- | -- | Details |
| C12333 | BRD-K31372389 | BRD-K31372389 | -- | -- | -- | Details |
| C12334 | BRD-K31373683 | BRD-K31373683 | -- | -- | -- | Details |
| C12335 | BRD-K31374463 | vecuronium | CHRNA2 | Acetylcholine receptor antagonist | -- | Details |
| C12336 | BRD-K31377965 | BRD-K31377965 | -- | -- | -- | Details |
| C12337 | BRD-K31378663 | BRD-K31378663 | -- | -- | -- | Details |
| C12338 | BRD-K31380618 | BRD-K31380618 | -- | -- | -- | Details |
| C12339 | BRD-K31385226 | BRD-K31385226 | -- | -- | -- | Details |
| C12340 | BRD-K31385749 | ivabradine | HCN4; HCN1; HCN3 | HCN channel antagonist; Sodium channel blocker; Potassium channel blocker | -- | Details |
| C12341 | BRD-K31387465 | BRD-K31387465 | -- | -- | -- | Details |
| C12342 | BRD-K31390971 | BRD-K31390971 | -- | -- | -- | Details |
| C12343 | BRD-K31392657 | BRD-K31392657 | -- | -- | -- | Details |
| C12344 | BRD-K31393518 | BRD-K31393518 | -- | -- | -- | Details |
| C12345 | BRD-K31406481 | VU-0155056 | -- | -- | -- | Details |
| C12346 | BRD-K31407552 | BRD-K31407552 | -- | -- | -- | Details |
| C12347 | BRD-K31408750 | BRD-K31408750 | -- | -- | -- | Details |
| C12348 | BRD-K31411295 | BRD-K31411295 | -- | -- | -- | Details |
| C12349 | BRD-K31412180 | BRD-K31412180 | -- | -- | -- | Details |
| C12350 | BRD-K31415071 | BRD-K31415071 | -- | -- | -- | Details |
| C12351 | BRD-K31418530 | BRD-K31418530 | -- | -- | -- | Details |
| C12352 | BRD-K31422806 | BRD-K31422806 | -- | -- | -- | Details |
| C12353 | BRD-K31423326 | BRD-K31423326 | -- | -- | -- | Details |
| C12354 | BRD-K31427141 | BRD-K31427141 | -- | -- | -- | Details |
| C12355 | BRD-K31435439 | SA-1457458 | -- | -- | -- | Details |
| C12356 | BRD-K31437957 | BRD-K31437957 | -- | -- | -- | Details |
| C12357 | BRD-K31439714 | BRD-K31439714 | -- | -- | -- | Details |
| C12358 | BRD-K31441680 | BRD-K31441680 | -- | -- | -- | Details |
| C12359 | BRD-K31441776 | SA-1921816 | -- | -- | -- | Details |
| C12360 | BRD-K31441930 | BRD-K31441930 | -- | -- | -- | Details |
| C12361 | BRD-K31444894 | SA-1921867 | -- | -- | -- | Details |
| C12362 | BRD-K31447894 | pravastatin | HMGCR | HMGCR inhibitor | -- | Details |
| C12363 | BRD-K31449336 | BRD-K31449336 | -- | -- | -- | Details |
| C12364 | BRD-K31450967 | ST-014075 | -- | -- | -- | Details |
| C12365 | BRD-K31453413 | BRD-K31453413 | -- | -- | -- | Details |
| C12366 | BRD-K31455027 | BRD-K31455027 | -- | -- | -- | Details |
| C12367 | BRD-K31460017 | BRD-K31460017 | -- | -- | -- | Details |
| C12368 | BRD-K31460632 | BRD-K31460632 | -- | -- | norfenfluramine | Details |
| C12369 | BRD-K31462164 | BRD-K31462164 | -- | -- | -- | Details |
| C12370 | BRD-K31462841 | BRD-K31462841 | -- | -- | -- | Details |
| C12371 | BRD-K31466024 | BRD-K31466024 | -- | -- | -- | Details |
| C12372 | BRD-K31467596 | BRD-K31467596 | -- | -- | -- | Details |
| C12373 | BRD-K31471398 | dihydrexidine | DRD1 | Dopamine receptor agonist | -- | Details |
| C12374 | BRD-K31476763 | AZD-9668 | -- | -- | -- | Details |
| C12375 | BRD-K31477169 | BRD-K31477169 | -- | -- | methyl-everninic-acid | Details |
| C12376 | BRD-K31479060 | BRD-K31479060 | -- | -- | -- | Details |
| C12377 | BRD-K31479652 | BRD-K31479652 | -- | -- | -- | Details |
| C12378 | BRD-K31483891 | BRD-K31483891 | -- | -- | -- | Details |
| C12379 | BRD-K31484631 | rifabutin | -- | -- | -- | Details |
| C12380 | BRD-K31485493 | BRD-K31485493 | -- | -- | -- | Details |
| C12381 | BRD-K31487013 | BRD-K31487013 | -- | -- | -- | Details |
| C12382 | BRD-K31487236 | BRD-K31487236 | -- | -- | -- | Details |
| C12383 | BRD-K31487253 | BRD-K31487253 | -- | -- | -- | Details |
| C12384 | BRD-K31490008 | BRD-K31490008 | -- | -- | -- | Details |
| C12385 | BRD-K31491153 | 1-phenylbiguanide | -- | -- | 1-PHENYLBIGUANIDE | Details |
| C12386 | BRD-K31494307 | BRD-K31494307 | -- | -- | -- | Details |
| C12387 | BRD-K31495718 | AZD-7687 | -- | -- | -- | Details |
| C12388 | BRD-K31503053 | BRD-K31503053 | -- | -- | -- | Details |
| C12389 | BRD-K31510624 | BRD-K31510624 | -- | -- | -- | Details |
| C12390 | BRD-K31510639 | BRD-K31510639 | -- | -- | -- | Details |
| C12391 | BRD-K31519811 | PF-02545920 | PDE10A | Phosphodiesterase inhibitor | -- | Details |
| C12392 | BRD-K31521981 | BRD-K31521981 | -- | -- | -- | Details |
| C12393 | BRD-K31526203 | BRD-K31526203 | -- | -- | -- | Details |
| C12394 | BRD-K31530457 | BRD-K31530457 | -- | -- | -- | Details |
| C12395 | BRD-K31533112 | BRD-K31533112 | -- | -- | -- | Details |
| C12396 | BRD-K31534764 | fluvoxamine | SLC6A4 | Selective serotonin reuptake inhibitor | -- | Details |
| C12397 | BRD-K31536290 | BRD-K31536290 | -- | -- | -- | Details |
| C12398 | BRD-K31538032 | BRD-K31538032 | -- | -- | -- | Details |
| C12399 | BRD-K31542390 | BRD-K31542390 | -- | -- | mycophenolic-acid | Details |
| C12400 | BRD-K31545458 | BRD-K31545458 | -- | -- | -- | Details |
| C12401 | BRD-K31546068 | BRD-K31546068 | -- | -- | -- | Details |
| C12402 | BRD-K31553034 | zibotentan | EDNRA | Endothelin receptor antagonist | -- | Details |
| C12403 | BRD-K31553917 | BRD-K31553917 | -- | -- | -- | Details |